These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 21359645)

  • 1. Drug and dietary interactions of warfarin and novel oral anticoagulants: an update.
    Nutescu E; Chuatrisorn I; Hellenbart E
    J Thromb Thrombolysis; 2011 Apr; 31(3):326-43. PubMed ID: 21359645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic drug interactions of the non-vitamin K antagonist oral anticoagulants (NOACs).
    Gelosa P; Castiglioni L; Tenconi M; Baldessin L; Racagni G; Corsini A; Bellosta S
    Pharmacol Res; 2018 Sep; 135():60-79. PubMed ID: 30040996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral anticoagulation with Factor Xa and thrombin inhibitors: Is there an alternative to warfarin?
    Zikria J; Ansell J
    Discov Med; 2009 Dec; 8(43):196-203. PubMed ID: 20040270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory and Clinical Monitoring of Direct Acting Oral Anticoagulants: What Clinicians Need to Know.
    Conway SE; Hwang AY; Ponte CD; Gums JG
    Pharmacotherapy; 2017 Feb; 37(2):236-248. PubMed ID: 27983747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New oral anticoagulants: comparative pharmacology with vitamin K antagonists.
    Scaglione F
    Clin Pharmacokinet; 2013 Feb; 52(2):69-82. PubMed ID: 23292752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation.
    Lee SR; Choi EK; Kwon S; Han KD; Jung JH; Cha MJ; Oh S; Lip GYH
    Stroke; 2019 Aug; 50(8):2245-2249. PubMed ID: 31208303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new oral anticoagulants: a challenge for hospital formularies.
    Merli GJ
    Hosp Pract (1995); 2012 Aug; 40(3):126-8. PubMed ID: 23086101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW; Barillari G
    J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Old and new oral anticoagulants: Food, herbal medicines and drug interactions.
    Di Minno A; Frigerio B; Spadarella G; Ravani A; Sansaro D; Amato M; Kitzmiller JP; Pepi M; Tremoli E; Baldassarre D
    Blood Rev; 2017 Jul; 31(4):193-203. PubMed ID: 28196633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Edoxaban: A direct oral anticoagulant.
    Poulakos M; Walker JN; Baig U; David T
    Am J Health Syst Pharm; 2017 Feb; 74(3):117-129. PubMed ID: 28122753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Clinical Significance of Drug-Food Interactions of Direct Oral Anticoagulants.
    Grześk G; Rogowicz D; Wołowiec Ł; Ratajczak A; Gilewski W; Chudzińska M; Sinkiewicz A; Banach J
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of oral anticoagulants in patients with atrial fibrillation.
    Greenspon AJ
    Postgrad Med; 2012 Nov; 124(6):7-16. PubMed ID: 23322134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments.
    Eek AK; Øie E; Granas AG
    Eur J Clin Pharmacol; 2018 Mar; 74(3):323-330. PubMed ID: 29149366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB
    BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243
    [No Abstract]   [Full Text] [Related]  

  • 16. Emerging anticoagulant therapies for atrial fibrillation: new options, new challenges.
    Mangiafico RA; Mangiafico M
    Curr Med Chem; 2012; 19(27):4688-98. PubMed ID: 22830344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of the new oral anticoagulants: opportunities and challenges.
    Yeh CH; Hogg K; Weitz JI
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1056-65. PubMed ID: 25792448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disadvantages of VKA and requirements for novel anticoagulants.
    Shameem R; Ansell J
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):103-14. PubMed ID: 23953899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of novel oral anticoagulants for patients with atrial fibrillation: systematic review and clinical implications.
    Albert NM
    Heart Lung; 2014; 43(1):48-59. PubMed ID: 24373340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Treatment of Venous Thromboembolism in the Elderly.
    Boey JP; Gallus A
    Drugs Aging; 2016 Jul; 33(7):475-90. PubMed ID: 27255713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.